Studies | EBMT

Top

Study type

Disease

Group

Type of transplant / Cell therapy

Text

The influence of pre-transplant immune dysregulation on transplant outcomes for combined immunodeficiencies and immune dysregulatory disorders

Retrospective Studies

Inherited disorders

Inborn Errors Working Party (IEWP)

Type de traitement

Investigateur principal

Thomas Fox & Emma Morris

L'influence de la dysrégulation immunitaire pré-transplantation sur les résultats de la greffe pour les immunodéficiences combinées et les troubles dysrégulateurs du système immunitaire

Études rétrospectives

Troubles héréditaires

Inborn Errors Working Party (IEWP)

Type de traitement

Investigateur principal

Thomas Fox & Emma Morris

Outcomes of pediatric patients with acute leukemias given either post-transplant cyclophosphamide or TCR αβ/CD19+ depleted HLA-haploidentical transplantation

Études rétrospectives

Leucémie Aiguë Lymphoblastique (LAL)

Leucémie Myéloïde Aiguë (LMA)

Paediatric Diseases Working Party (PDWP)

Type de traitement

Allogénique - Haplo-identique

Investigateur principal

Franco Locatelli

Survey on fertility procedures and outcomes for patients treated with CAR-T cell therapy

Closed Survey/Study

Cellular Therapy & Immunobiology Working Party (CTIWP)

Type de traitement

Investigateur principal

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT IN CARTILAGE HAIR HYPOPLASIA (CHH) A JOINT EBMT-CIBMTR STUDY

Retrospective Studies

Inherited disorders

Inborn Errors Working Party (IEWP)

Type de traitement

Investigateur principal

Allogeneic haematopoietic stem cell transplantation in infantile osteopetrosis

Retrospective Studies

Inherited disorders

Type de traitement

Investigateur principal

Outcome of haematopoietic stem cell transplant (HSCT) in patients with Chediak Higashi syndrome

Retrospective Studies

Inherited disorders

Inborn Errors Working Party (IEWP)

Type de traitement

Investigateur principal

A survey on secondary neoplasm post CART

Études rétrospectives

Toutes les maladies

GoCART Coalition

Type de traitement

Investigateur principal

Impact of prior B-cell directed immunotherapy (BCDI) on the outcome of CD19 CAR-T cell therapy in aggressive B-cell malignancies, on behalf of the GoCART Coalition initiative.

Retrospective Studies

Non-Hodgkin’s Lymphoma (NHL)

GoCART Coalition

Type de traitement

Investigateur principal

The role of bridging therapy before CAR-T cell therapy in diffuse large B-cell lymphoma (DLBCL): An analysis of the LWP of the EBMT and the GoCART coalition.

Retrospective Studies

Non-Hodgkin’s Lymphoma (NHL)

GoCART Coalition

Type de traitement

Investigateur principal

Philipp Berning

CAR-T in elderly patients

Études rétrospectives

Lymphome non hodgkinien (LNH)

Cellular Therapy & Immunobiology Working Party (CTIWP)

Type de traitement

Investigateur principal

Maribavir use for CMV infection in allogeneic stem cell transplantation: the real-world experience. A retrospective study of IDWP EBMT

Retrospective Studies

Complications: infectious

Infectious Diseases Working Party (IDWP)

Type de traitement

Investigateur principal

Annalisa Paviglianiti